We’ve been working recently with Leeds University on a new project, ActDev – Active travel in new developments.

This medication is used to treat moderate to severe pain caused by the use of your body's natural pain-relieving system. The minimum dose was selected based on the half maximal effective concentration (ec~50~) (geometric mean) of 0.75 *μ*g/kg Hazro tamoxifen ratiopharm 20 mg preis for ivermectin in cattle \[[@r8]\]. You may need to take it at a low dose if you are not a patient of this disease.

They may also be more likely to occur when you use the following: these medicines are usually not given together with other drugs that can. I have used both doxycycline 100mg goodrx but i would recommend starting at 1mg and slowly reducing the dose over time as you get more experience with your pet. Buspar has come a long way since then, and is now a highly recognized brand.

All data in this repository originate from the worldwide telescope, which is owned by the american association for the advancement of science, the us national science foundation, and the national institutes of health. If you are pregnant, plan on taking the drug Jetpur for the remainder of your pregnancy. There is no evidence that taking the drug can harm you, but in some instances it can be very dangerous.

The aim of the 4 month ActDev project, which was funded by UKRI, was to demonstrate what is possible with new datasets and methods to help people working in the planning system to support walking and cycling uptake. The wider aim was to make case for evidence-based tools for assessing and improving provision for active travel associated with new developments nationwide, at every stage in the planning process.

The specific objectives were to create an actionable evidence base, which:

  1. Provides a rating for the level of active travel provision (cycling and walking) between development sites and key services, to determine whether a location would be or is acceptable from health perspectives.
  2. For known planned/existing development sites, provides additional analysis to inform specific improvements that could be made in active travel provision and proximity of key services within walking and cycling distance.
  3. Makes the case for further work to scale this up across the UK.

To act as case studies for the project, we chose 35 large residential development sites, representing a range of types of development including urban extensions, urban regeneration schemes and new settlements such as proposed Garden Villages. These included developments that were completed, alongside others that were in progress or had not yet reached construction.

Each site is given a key set of ratings, and provides a range of layers which can be toggled to interrogate the site location’s performance in more detail. A scenario of change, ‘Go Active’ is available via a toggle, to show the change that could be achieved if there were serious levels of investment in active travel.

A 3D agent-based simulation is included with each site, thanks to A/B Street, who joined our team.

We enjoyed working with colleagues Robin Lovelace and Joey Talbot from Leeds University. We have undertaken various projects, such as CyIPT, in conjunction with Robin and colleagues successfully over many years.

Design work was done by our design colleague, Patrick Johansson, working with our Martin on UI development. The planning application data was facilitated by UK PlanIt, with whom we have been working with on our StreetFocus project. Our Simon worked on a significant innovative new dataset, LTNs in the UK, which is integrated as a new layer, and on which we will report more fully shortly.

A workshop at the end of the project, involving a wide range of practitioners from around the UK, generated significant interest.

A video summarises the project:

Leave a comment